Sa. Williams et al., SUBCELLULAR ALTERATIONS IN CARDIAC PHOSPHOLIPASE-D ACTIVITY IN CHRONIC DIABETES, Prostaglandins, leukotrienes and essential fatty acids, 57(1), 1997, pp. 95-99
Several studies have suggested that myocardial phospholipase D (PLD) a
nd its hydrolytic product, phosphatidic acid (PtdOH), may regulate Ca2
+ movements and contractile performance of the heart. Since abnormal i
ntracellular Ca2+ handling is a major factor of myocardial dysfunction
in chronic diabetes, we examined subcellular changes in PLD activity
in myocardium from insulin-dependent diabetic rats. Diabetes in rats w
as induced by a single i.v. injection of streptozotocin (65 mg/kg body
wt) and 8 weeks later the ventricular tissue was processed for the is
olation of sarcolemma, sarcoplasmic reticulum and mitochondria. Compar
ed to age-matched controls, the sarcolemmal, sarcoplasmic reticular an
d mitochondrial PLD activities were significantly depressed in the dia
betic animals. The depressed sarcolemmal PLD activity was normalized,
whereas the sarcoplasmic reticular and mitochondrial enzyme activities
were partially reversed upon treating the 6-week diabetic rats with i
nsulin for a period of 2 weeks. These data suggest that the reduction
of PLD-derived PtdOH may lead to an impairment in this phospholipid si
gnal transduction pathway and subsequent cardiac dysfunction in chroni
c diabetes.